UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Tisotumab Vedotin-tftv (Tivdak)
Situation
Tisotumab vedotin-tftv (Tivdak) 40 mg SDV for injection was approved for addition to the health system formulary at the January 2022 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Tisotumab vedotin-tftv (Tivdak) 40 mg SDV for injection
Assessment/Recommendation
Change effective: Tuesday, February 22, 2022
System P&T voted to include the following products on the UNC Health Medication Formulary:
- Tisotumab vedotin-tftv 40 mg SDV for injection
Note: Stock of this formulary product may vary at individual entities